A prospective cohort study for prognostic value of LR11 in patients with malignant lymphoma (LR11-ML-study)

A prospective cohort study for prognostic value of LR11 in patients with malignant lymphoma (LR11-ML-study) - LR11-ML-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013389

Enrollment

150

Registered

2014-03-11

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with written consent of the study.

Exclusion criteria

Exclusion criteria: Patients who could not obtain written consent.

Design outcomes

Primary

Measure	Time frame
The association of tumor LR11 expression and serum soluble LR11 level at diagnosis and complete response rate.	—

Secondary

Measure	Time frame
The association of LR11 level and recurrence rate, overall survival rate, disease free survival rate, and other predictive markers.	—

Countries

Japan

Contacts

Public ContactChikako Ohwada

Department of Clinical Cell Biology, Chiba University Graduate School of Medicine Division of Hematology

chikako_ohwada@faculty.chiba-u.jp043-225-6502

Outcome results